الفهرس 
CoverArabicOnly 14 pages are availabe for public view
 |  | from | 111 |  |  |
| | | from | 111 | | |
Abstract
Neoadjuvant therapy has been used as a primary treatment for locally advanced or inflammatory breast cancer, and recently extended to operable breast cancer. However, only a few studies have published data concerning the outcomes of patients with stages II abd III breast cancer after neoadjuvant therapy. Neoadjuvant therapy resulted in increased operability for breast conservation and decreased dermatoplasty.